nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—kidney cancer—thyroid cancer	0.269	0.509	CtDrD
Paclitaxel—lung cancer—thyroid cancer	0.26	0.491	CtDrD
Paclitaxel—ABCC1—Vandetanib—thyroid cancer	0.0359	0.129	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—thyroid cancer	0.034	0.122	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—thyroid cancer	0.0247	0.0886	CbGbCtD
Paclitaxel—ABCG2—Vandetanib—thyroid cancer	0.0241	0.0861	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—thyroid cancer	0.0185	0.0663	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—thyroid cancer	0.0185	0.0663	CbGbCtD
Paclitaxel—ABCC2—Sorafenib—thyroid cancer	0.016	0.0574	CbGbCtD
Paclitaxel—ABCG2—Sorafenib—thyroid cancer	0.0145	0.0519	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—thyroid cancer	0.0131	0.0471	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0107	0.0383	CbGbCtD
Paclitaxel—CYP3A7—Sorafenib—thyroid cancer	0.0107	0.0383	CbGbCtD
Paclitaxel—ABCC2—Doxorubicin—thyroid cancer	0.00973	0.0348	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—thyroid cancer	0.0088	0.0315	CbGbCtD
Paclitaxel—CYP3A5—Sorafenib—thyroid cancer	0.00803	0.0288	CbGbCtD
Paclitaxel—CYP2C8—Sorafenib—thyroid cancer	0.00772	0.0277	CbGbCtD
Paclitaxel—CYP2C9—Sorafenib—thyroid cancer	0.00539	0.0193	CbGbCtD
Paclitaxel—ABCB1—Sorafenib—thyroid cancer	0.00523	0.0187	CbGbCtD
Paclitaxel—CYP3A4—Vandetanib—thyroid cancer	0.0052	0.0186	CbGbCtD
Paclitaxel—ABCB1—Doxorubicin—thyroid cancer	0.00317	0.0114	CbGbCtD
Paclitaxel—CYP3A4—Sorafenib—thyroid cancer	0.00313	0.0112	CbGbCtD
Paclitaxel—CYP3A4—Doxorubicin—thyroid cancer	0.0019	0.00681	CbGbCtD
Paclitaxel—BCL2—neck—thyroid cancer	0.00139	0.0459	CbGeAlD
Paclitaxel—MAP2—neck—thyroid cancer	0.00121	0.0398	CbGeAlD
Paclitaxel—TUBB3—Afatinib—Vandetanib—thyroid cancer	0.00101	0.417	CbGdCrCtD
Paclitaxel—NR1I2—head—thyroid cancer	0.000988	0.0326	CbGeAlD
Paclitaxel—TUBB8—head—thyroid cancer	0.000947	0.0313	CbGeAlD
Paclitaxel—MAP2—saliva-secreting gland—thyroid cancer	0.00094	0.031	CbGeAlD
Paclitaxel—MAPT—thyroid gland—thyroid cancer	0.000927	0.0306	CbGeAlD
Paclitaxel—MAP4—thyroid gland—thyroid cancer	0.000729	0.024	CbGeAlD
Paclitaxel—MAP2—trachea—thyroid cancer	0.000725	0.0239	CbGeAlD
Paclitaxel—TUBB2B—saliva-secreting gland—thyroid cancer	0.000702	0.0232	CbGeAlD
Paclitaxel—TUBB—saliva-secreting gland—thyroid cancer	0.000665	0.0219	CbGeAlD
Paclitaxel—BCL2—thyroid gland—thyroid cancer	0.000662	0.0219	CbGeAlD
Paclitaxel—TUBB2A—saliva-secreting gland—thyroid cancer	0.000661	0.0218	CbGeAlD
Paclitaxel—TUBB6—saliva-secreting gland—thyroid cancer	0.000652	0.0215	CbGeAlD
Paclitaxel—TUBB3—head—thyroid cancer	0.000646	0.0213	CbGeAlD
Paclitaxel—MAP4—head—thyroid cancer	0.000646	0.0213	CbGeAlD
Paclitaxel—TUBB1—head—thyroid cancer	0.000632	0.0209	CbGeAlD
Paclitaxel—TUBB4B—Afatinib—Vandetanib—thyroid cancer	0.000627	0.258	CbGdCrCtD
Paclitaxel—BCL2—head—thyroid cancer	0.000588	0.0194	CbGeAlD
Paclitaxel—MAPT—lymph node—thyroid cancer	0.000576	0.019	CbGeAlD
Paclitaxel—MAP2—thyroid gland—thyroid cancer	0.000574	0.0189	CbGeAlD
Paclitaxel—ABCC10—saliva-secreting gland—thyroid cancer	0.000571	0.0188	CbGeAlD
Paclitaxel—TUBB4B—saliva-secreting gland—thyroid cancer	0.000567	0.0187	CbGeAlD
Paclitaxel—TUBB2B—trachea—thyroid cancer	0.000542	0.0179	CbGeAlD
Paclitaxel—TUBB—trachea—thyroid cancer	0.000513	0.0169	CbGeAlD
Paclitaxel—TUBB2A—trachea—thyroid cancer	0.00051	0.0168	CbGeAlD
Paclitaxel—MAP2—head—thyroid cancer	0.000509	0.0168	CbGeAlD
Paclitaxel—TUBB6—trachea—thyroid cancer	0.000503	0.0166	CbGeAlD
Paclitaxel—TUBB6—Erlotinib—Vandetanib—thyroid cancer	0.000478	0.196	CbGdCrCtD
Paclitaxel—MAP4—lymph node—thyroid cancer	0.000453	0.0149	CbGeAlD
Paclitaxel—TUBB4A—thyroid gland—thyroid cancer	0.000443	0.0146	CbGeAlD
Paclitaxel—ABCC10—trachea—thyroid cancer	0.00044	0.0145	CbGeAlD
Paclitaxel—TUBB4B—trachea—thyroid cancer	0.000437	0.0144	CbGeAlD
Paclitaxel—TUBB2B—thyroid gland—thyroid cancer	0.000429	0.0141	CbGeAlD
Paclitaxel—BCL2—lymph node—thyroid cancer	0.000411	0.0136	CbGeAlD
Paclitaxel—TUBB—thyroid gland—thyroid cancer	0.000406	0.0134	CbGeAlD
Paclitaxel—TUBB2A—thyroid gland—thyroid cancer	0.000403	0.0133	CbGeAlD
Paclitaxel—TUBB6—thyroid gland—thyroid cancer	0.000398	0.0131	CbGeAlD
Paclitaxel—TUBB4A—head—thyroid cancer	0.000393	0.013	CbGeAlD
Paclitaxel—TUBB2B—head—thyroid cancer	0.00038	0.0125	CbGeAlD
Paclitaxel—TUBB2A—head—thyroid cancer	0.000358	0.0118	CbGeAlD
Paclitaxel—MAP2—lymph node—thyroid cancer	0.000356	0.0118	CbGeAlD
Paclitaxel—TUBB6—head—thyroid cancer	0.000353	0.0116	CbGeAlD
Paclitaxel—ABCC10—thyroid gland—thyroid cancer	0.000348	0.0115	CbGeAlD
Paclitaxel—TUBB4B—thyroid gland—thyroid cancer	0.000346	0.0114	CbGeAlD
Paclitaxel—ABCG2—saliva-secreting gland—thyroid cancer	0.000334	0.011	CbGeAlD
Paclitaxel—TUBB6—Afatinib—Vandetanib—thyroid cancer	0.000313	0.128	CbGdCrCtD
Paclitaxel—ABCC1—trachea—thyroid cancer	0.000311	0.0103	CbGeAlD
Paclitaxel—TUBB4B—head—thyroid cancer	0.000307	0.0101	CbGeAlD
Paclitaxel—CYP19A1—thyroid gland—thyroid cancer	0.000293	0.00967	CbGeAlD
Paclitaxel—TUBB4A—lymph node—thyroid cancer	0.000275	0.00909	CbGeAlD
Paclitaxel—CYP1B1—thyroid gland—thyroid cancer	0.000274	0.00904	CbGeAlD
Paclitaxel—TUBB2B—lymph node—thyroid cancer	0.000266	0.00878	CbGeAlD
Paclitaxel—CYP19A1—head—thyroid cancer	0.00026	0.00858	CbGeAlD
Paclitaxel—TUBB—lymph node—thyroid cancer	0.000252	0.00831	CbGeAlD
Paclitaxel—TUBB2A—lymph node—thyroid cancer	0.000251	0.00827	CbGeAlD
Paclitaxel—TUBB6—lymph node—thyroid cancer	0.000247	0.00816	CbGeAlD
Paclitaxel—ABCC1—thyroid gland—thyroid cancer	0.000246	0.00813	CbGeAlD
Paclitaxel—CYP1B1—head—thyroid cancer	0.000243	0.00802	CbGeAlD
Paclitaxel—ABCC10—lymph node—thyroid cancer	0.000216	0.00714	CbGeAlD
Paclitaxel—TUBB4B—lymph node—thyroid cancer	0.000215	0.00709	CbGeAlD
Paclitaxel—ABCG2—thyroid gland—thyroid cancer	0.000204	0.00673	CbGeAlD
Paclitaxel—CYP19A1—lymph node—thyroid cancer	0.000182	0.00601	CbGeAlD
Paclitaxel—ABCC2—lymph node—thyroid cancer	0.000174	0.00573	CbGeAlD
Paclitaxel—CYP1B1—lymph node—thyroid cancer	0.00017	0.00562	CbGeAlD
Paclitaxel—ABCC1—lymph node—thyroid cancer	0.000153	0.00505	CbGeAlD
Paclitaxel—ABCB1—trachea—thyroid cancer	0.000127	0.0042	CbGeAlD
Paclitaxel—ABCG2—lymph node—thyroid cancer	0.000127	0.00418	CbGeAlD
Paclitaxel—ABCB1—thyroid gland—thyroid cancer	0.000101	0.00332	CbGeAlD
Paclitaxel—ABCB1—head—thyroid cancer	8.92e-05	0.00294	CbGeAlD
Paclitaxel—ABCB1—lymph node—thyroid cancer	6.25e-05	0.00206	CbGeAlD
Paclitaxel—Ataxia—Doxorubicin—thyroid cancer	5.36e-05	0.000473	CcSEcCtD
Paclitaxel—Blood creatinine increased—Doxorubicin—thyroid cancer	5.34e-05	0.000471	CcSEcCtD
Paclitaxel—Influenza—Epirubicin—thyroid cancer	5.32e-05	0.00047	CcSEcCtD
Paclitaxel—Dysphagia—Epirubicin—thyroid cancer	5.32e-05	0.00047	CcSEcCtD
Paclitaxel—Dehydration—Doxorubicin—thyroid cancer	5.3e-05	0.000468	CcSEcCtD
Paclitaxel—Liver function test abnormal—Doxorubicin—thyroid cancer	5.26e-05	0.000464	CcSEcCtD
Paclitaxel—Dry skin—Doxorubicin—thyroid cancer	5.22e-05	0.000461	CcSEcCtD
Paclitaxel—Pancreatitis—Epirubicin—thyroid cancer	5.22e-05	0.00046	CcSEcCtD
Paclitaxel—Vomiting—Sorafenib—thyroid cancer	5.21e-05	0.000459	CcSEcCtD
Paclitaxel—Orthostatic hypotension—Doxorubicin—thyroid cancer	5.2e-05	0.000459	CcSEcCtD
Paclitaxel—Abdominal pain upper—Doxorubicin—thyroid cancer	5.2e-05	0.000459	CcSEcCtD
Paclitaxel—Hypokalaemia—Doxorubicin—thyroid cancer	5.19e-05	0.000458	CcSEcCtD
Paclitaxel—Rash—Sorafenib—thyroid cancer	5.16e-05	0.000456	CcSEcCtD
Paclitaxel—Dermatitis—Sorafenib—thyroid cancer	5.16e-05	0.000455	CcSEcCtD
Paclitaxel—Breast disorder—Doxorubicin—thyroid cancer	5.15e-05	0.000454	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	5.13e-05	0.000453	CcSEcCtD
Paclitaxel—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	5.13e-05	0.000453	CcSEcCtD
Paclitaxel—Headache—Sorafenib—thyroid cancer	5.13e-05	0.000453	CcSEcCtD
Paclitaxel—Bronchitis—Epirubicin—thyroid cancer	5.12e-05	0.000452	CcSEcCtD
Paclitaxel—Nasopharyngitis—Doxorubicin—thyroid cancer	5.09e-05	0.00045	CcSEcCtD
Paclitaxel—Pancytopenia—Epirubicin—thyroid cancer	5.05e-05	0.000446	CcSEcCtD
Paclitaxel—Muscular weakness—Doxorubicin—thyroid cancer	5.03e-05	0.000443	CcSEcCtD
Paclitaxel—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	5.03e-05	0.000443	CcSEcCtD
Paclitaxel—Dysuria—Epirubicin—thyroid cancer	4.98e-05	0.000439	CcSEcCtD
Paclitaxel—Neutropenia—Epirubicin—thyroid cancer	4.98e-05	0.000439	CcSEcCtD
Paclitaxel—Abdominal distension—Doxorubicin—thyroid cancer	4.96e-05	0.000437	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Epirubicin—thyroid cancer	4.95e-05	0.000436	CcSEcCtD
Paclitaxel—Dysphagia—Doxorubicin—thyroid cancer	4.92e-05	0.000434	CcSEcCtD
Paclitaxel—Influenza—Doxorubicin—thyroid cancer	4.92e-05	0.000434	CcSEcCtD
Paclitaxel—Pollakiuria—Epirubicin—thyroid cancer	4.92e-05	0.000434	CcSEcCtD
Paclitaxel—Nausea—Sorafenib—thyroid cancer	4.86e-05	0.000429	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Epirubicin—thyroid cancer	4.86e-05	0.000429	CcSEcCtD
Paclitaxel—Weight increased—Epirubicin—thyroid cancer	4.84e-05	0.000427	CcSEcCtD
Paclitaxel—Pancreatitis—Doxorubicin—thyroid cancer	4.83e-05	0.000426	CcSEcCtD
Paclitaxel—Weight decreased—Epirubicin—thyroid cancer	4.81e-05	0.000425	CcSEcCtD
Paclitaxel—Hyperglycaemia—Epirubicin—thyroid cancer	4.8e-05	0.000424	CcSEcCtD
Paclitaxel—Pneumonia—Epirubicin—thyroid cancer	4.77e-05	0.000421	CcSEcCtD
Paclitaxel—Infestation NOS—Epirubicin—thyroid cancer	4.75e-05	0.000419	CcSEcCtD
Paclitaxel—Infestation—Epirubicin—thyroid cancer	4.75e-05	0.000419	CcSEcCtD
Paclitaxel—Bronchitis—Doxorubicin—thyroid cancer	4.74e-05	0.000418	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	4.7e-05	0.000415	CcSEcCtD
Paclitaxel—Pancytopenia—Doxorubicin—thyroid cancer	4.68e-05	0.000413	CcSEcCtD
Paclitaxel—Renal failure—Epirubicin—thyroid cancer	4.66e-05	0.000412	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Epirubicin—thyroid cancer	4.65e-05	0.00041	CcSEcCtD
Paclitaxel—Stomatitis—Epirubicin—thyroid cancer	4.63e-05	0.000408	CcSEcCtD
Paclitaxel—Conjunctivitis—Epirubicin—thyroid cancer	4.61e-05	0.000407	CcSEcCtD
Paclitaxel—Urinary tract infection—Epirubicin—thyroid cancer	4.61e-05	0.000407	CcSEcCtD
Paclitaxel—Dysuria—Doxorubicin—thyroid cancer	4.6e-05	0.000406	CcSEcCtD
Paclitaxel—Neutropenia—Doxorubicin—thyroid cancer	4.6e-05	0.000406	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Doxorubicin—thyroid cancer	4.58e-05	0.000404	CcSEcCtD
Paclitaxel—Pollakiuria—Doxorubicin—thyroid cancer	4.55e-05	0.000401	CcSEcCtD
Paclitaxel—Haematuria—Epirubicin—thyroid cancer	4.52e-05	0.000399	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Doxorubicin—thyroid cancer	4.49e-05	0.000397	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Epirubicin—thyroid cancer	4.49e-05	0.000396	CcSEcCtD
Paclitaxel—Weight increased—Doxorubicin—thyroid cancer	4.48e-05	0.000395	CcSEcCtD
Paclitaxel—Epistaxis—Epirubicin—thyroid cancer	4.48e-05	0.000395	CcSEcCtD
Paclitaxel—Weight decreased—Doxorubicin—thyroid cancer	4.46e-05	0.000393	CcSEcCtD
Paclitaxel—Sinusitis—Epirubicin—thyroid cancer	4.45e-05	0.000393	CcSEcCtD
Paclitaxel—Hyperglycaemia—Doxorubicin—thyroid cancer	4.44e-05	0.000392	CcSEcCtD
Paclitaxel—Pneumonia—Doxorubicin—thyroid cancer	4.42e-05	0.00039	CcSEcCtD
Paclitaxel—Infestation—Doxorubicin—thyroid cancer	4.39e-05	0.000387	CcSEcCtD
Paclitaxel—Infestation NOS—Doxorubicin—thyroid cancer	4.39e-05	0.000387	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	4.35e-05	0.000384	CcSEcCtD
Paclitaxel—Bradycardia—Epirubicin—thyroid cancer	4.34e-05	0.000383	CcSEcCtD
Paclitaxel—Renal failure—Doxorubicin—thyroid cancer	4.32e-05	0.000381	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Doxorubicin—thyroid cancer	4.3e-05	0.00038	CcSEcCtD
Paclitaxel—Haemoglobin—Epirubicin—thyroid cancer	4.28e-05	0.000378	CcSEcCtD
Paclitaxel—Stomatitis—Doxorubicin—thyroid cancer	4.28e-05	0.000378	CcSEcCtD
Paclitaxel—Rhinitis—Epirubicin—thyroid cancer	4.27e-05	0.000377	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—thyroid cancer	4.27e-05	0.000377	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—thyroid cancer	4.27e-05	0.000377	CcSEcCtD
Paclitaxel—Haemorrhage—Epirubicin—thyroid cancer	4.26e-05	0.000376	CcSEcCtD
Paclitaxel—Hypoaesthesia—Epirubicin—thyroid cancer	4.24e-05	0.000374	CcSEcCtD
Paclitaxel—Pharyngitis—Epirubicin—thyroid cancer	4.23e-05	0.000373	CcSEcCtD
Paclitaxel—Urinary tract disorder—Epirubicin—thyroid cancer	4.21e-05	0.000371	CcSEcCtD
Paclitaxel—Oedema peripheral—Epirubicin—thyroid cancer	4.2e-05	0.00037	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—thyroid cancer	4.19e-05	0.000369	CcSEcCtD
Paclitaxel—Connective tissue disorder—Epirubicin—thyroid cancer	4.19e-05	0.000369	CcSEcCtD
Paclitaxel—Urethral disorder—Epirubicin—thyroid cancer	4.18e-05	0.000368	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Doxorubicin—thyroid cancer	4.15e-05	0.000366	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—thyroid cancer	4.14e-05	0.000365	CcSEcCtD
Paclitaxel—Sinusitis—Doxorubicin—thyroid cancer	4.12e-05	0.000363	CcSEcCtD
Paclitaxel—Visual impairment—Epirubicin—thyroid cancer	4.11e-05	0.000362	CcSEcCtD
Paclitaxel—Erythema multiforme—Epirubicin—thyroid cancer	4.03e-05	0.000355	CcSEcCtD
Paclitaxel—Bradycardia—Doxorubicin—thyroid cancer	4.01e-05	0.000354	CcSEcCtD
Paclitaxel—Eye disorder—Epirubicin—thyroid cancer	3.98e-05	0.000351	CcSEcCtD
Paclitaxel—Tinnitus—Epirubicin—thyroid cancer	3.97e-05	0.00035	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—thyroid cancer	3.96e-05	0.00035	CcSEcCtD
Paclitaxel—Flushing—Epirubicin—thyroid cancer	3.95e-05	0.000349	CcSEcCtD
Paclitaxel—Cardiac disorder—Epirubicin—thyroid cancer	3.95e-05	0.000349	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—thyroid cancer	3.95e-05	0.000349	CcSEcCtD
Paclitaxel—Haemorrhage—Doxorubicin—thyroid cancer	3.94e-05	0.000348	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—thyroid cancer	3.92e-05	0.000346	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—thyroid cancer	3.91e-05	0.000345	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—thyroid cancer	3.89e-05	0.000343	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—thyroid cancer	3.88e-05	0.000343	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—thyroid cancer	3.87e-05	0.000342	CcSEcCtD
Paclitaxel—Angiopathy—Epirubicin—thyroid cancer	3.86e-05	0.000341	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—thyroid cancer	3.86e-05	0.000341	CcSEcCtD
Paclitaxel—Immune system disorder—Epirubicin—thyroid cancer	3.85e-05	0.000339	CcSEcCtD
Paclitaxel—Mediastinal disorder—Epirubicin—thyroid cancer	3.84e-05	0.000339	CcSEcCtD
Paclitaxel—Chills—Epirubicin—thyroid cancer	3.82e-05	0.000337	CcSEcCtD
Paclitaxel—Arrhythmia—Epirubicin—thyroid cancer	3.81e-05	0.000336	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—thyroid cancer	3.8e-05	0.000335	CcSEcCtD
Paclitaxel—Alopecia—Epirubicin—thyroid cancer	3.76e-05	0.000332	CcSEcCtD
Paclitaxel—Mental disorder—Epirubicin—thyroid cancer	3.73e-05	0.000329	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—thyroid cancer	3.73e-05	0.000329	CcSEcCtD
Paclitaxel—Malnutrition—Epirubicin—thyroid cancer	3.71e-05	0.000327	CcSEcCtD
Paclitaxel—Erythema—Epirubicin—thyroid cancer	3.71e-05	0.000327	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—thyroid cancer	3.68e-05	0.000325	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—thyroid cancer	3.67e-05	0.000324	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—thyroid cancer	3.66e-05	0.000323	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—thyroid cancer	3.66e-05	0.000323	CcSEcCtD
Paclitaxel—Flatulence—Epirubicin—thyroid cancer	3.65e-05	0.000322	CcSEcCtD
Paclitaxel—Tension—Epirubicin—thyroid cancer	3.64e-05	0.000321	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—thyroid cancer	3.63e-05	0.00032	CcSEcCtD
Paclitaxel—Nervousness—Epirubicin—thyroid cancer	3.6e-05	0.000318	CcSEcCtD
Paclitaxel—Back pain—Epirubicin—thyroid cancer	3.59e-05	0.000316	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—thyroid cancer	3.58e-05	0.000316	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—thyroid cancer	3.57e-05	0.000315	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—thyroid cancer	3.56e-05	0.000314	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—thyroid cancer	3.55e-05	0.000313	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—thyroid cancer	3.54e-05	0.000312	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—thyroid cancer	3.52e-05	0.000311	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—thyroid cancer	3.49e-05	0.000308	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—thyroid cancer	3.48e-05	0.000307	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—thyroid cancer	3.45e-05	0.000305	CcSEcCtD
Paclitaxel—Ill-defined disorder—Epirubicin—thyroid cancer	3.44e-05	0.000304	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—thyroid cancer	3.43e-05	0.000303	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—thyroid cancer	3.43e-05	0.000303	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—thyroid cancer	3.43e-05	0.000302	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—thyroid cancer	3.41e-05	0.000301	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—thyroid cancer	3.38e-05	0.000298	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—thyroid cancer	3.37e-05	0.000297	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—thyroid cancer	3.36e-05	0.000296	CcSEcCtD
Paclitaxel—Malaise—Epirubicin—thyroid cancer	3.34e-05	0.000295	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—thyroid cancer	3.33e-05	0.000294	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—thyroid cancer	3.33e-05	0.000294	CcSEcCtD
Paclitaxel—Syncope—Epirubicin—thyroid cancer	3.33e-05	0.000293	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—thyroid cancer	3.32e-05	0.000293	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—thyroid cancer	3.32e-05	0.000293	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—thyroid cancer	3.3e-05	0.000291	CcSEcCtD
Paclitaxel—Palpitations—Epirubicin—thyroid cancer	3.28e-05	0.000289	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—thyroid cancer	3.26e-05	0.000288	CcSEcCtD
Paclitaxel—Cough—Epirubicin—thyroid cancer	3.24e-05	0.000286	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—thyroid cancer	3.23e-05	0.000285	CcSEcCtD
Paclitaxel—Convulsion—Epirubicin—thyroid cancer	3.21e-05	0.000283	CcSEcCtD
Paclitaxel—Hypertension—Epirubicin—thyroid cancer	3.2e-05	0.000282	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—thyroid cancer	3.18e-05	0.000281	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—thyroid cancer	3.17e-05	0.00028	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—thyroid cancer	3.16e-05	0.000279	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—thyroid cancer	3.16e-05	0.000279	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—thyroid cancer	3.16e-05	0.000279	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—thyroid cancer	3.15e-05	0.000278	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—thyroid cancer	3.15e-05	0.000278	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	3.14e-05	0.000277	CcSEcCtD
Paclitaxel—Discomfort—Epirubicin—thyroid cancer	3.12e-05	0.000275	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—thyroid cancer	3.09e-05	0.000273	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—thyroid cancer	3.09e-05	0.000272	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—thyroid cancer	3.08e-05	0.000272	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—thyroid cancer	3.08e-05	0.000271	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—thyroid cancer	3.07e-05	0.000271	CcSEcCtD
Paclitaxel—Confusional state—Epirubicin—thyroid cancer	3.05e-05	0.000269	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—thyroid cancer	3.03e-05	0.000268	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—thyroid cancer	3.03e-05	0.000267	CcSEcCtD
Paclitaxel—Oedema—Epirubicin—thyroid cancer	3.03e-05	0.000267	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—thyroid cancer	3.02e-05	0.000266	CcSEcCtD
Paclitaxel—Infection—Epirubicin—thyroid cancer	3.01e-05	0.000265	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—thyroid cancer	2.99e-05	0.000264	CcSEcCtD
Paclitaxel—Shock—Epirubicin—thyroid cancer	2.98e-05	0.000263	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—thyroid cancer	2.97e-05	0.000262	CcSEcCtD
Paclitaxel—Nervous system disorder—Epirubicin—thyroid cancer	2.97e-05	0.000262	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—thyroid cancer	2.96e-05	0.000261	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—thyroid cancer	2.96e-05	0.000261	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—thyroid cancer	2.95e-05	0.000261	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—thyroid cancer	2.94e-05	0.000259	CcSEcCtD
Paclitaxel—Hyperhidrosis—Epirubicin—thyroid cancer	2.93e-05	0.000258	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—thyroid cancer	2.92e-05	0.000258	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—thyroid cancer	2.92e-05	0.000258	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—thyroid cancer	2.92e-05	0.000258	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—thyroid cancer	2.91e-05	0.000257	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	2.9e-05	0.000256	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—thyroid cancer	2.89e-05	0.000255	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—thyroid cancer	2.88e-05	0.000255	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—thyroid cancer	2.86e-05	0.000252	CcSEcCtD
Paclitaxel—Hypotension—Epirubicin—thyroid cancer	2.83e-05	0.00025	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—thyroid cancer	2.82e-05	0.000249	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—thyroid cancer	2.8e-05	0.000247	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—thyroid cancer	2.8e-05	0.000247	CcSEcCtD
Paclitaxel—Infection—Doxorubicin—thyroid cancer	2.78e-05	0.000245	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—thyroid cancer	2.76e-05	0.000243	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—thyroid cancer	2.76e-05	0.000243	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—thyroid cancer	2.75e-05	0.000242	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—thyroid cancer	2.74e-05	0.000242	CcSEcCtD
Paclitaxel—Insomnia—Epirubicin—thyroid cancer	2.74e-05	0.000242	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—thyroid cancer	2.73e-05	0.000241	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—thyroid cancer	2.72e-05	0.00024	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—thyroid cancer	2.72e-05	0.00024	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—thyroid cancer	2.71e-05	0.000239	CcSEcCtD
Paclitaxel—Dyspnoea—Epirubicin—thyroid cancer	2.7e-05	0.000238	CcSEcCtD
Paclitaxel—Somnolence—Epirubicin—thyroid cancer	2.69e-05	0.000237	CcSEcCtD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.67e-05	0.000587	CbGpPWpGaD
Paclitaxel—Anorexia—Doxorubicin—thyroid cancer	2.67e-05	0.000236	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—thyroid cancer	2.66e-05	0.000235	CcSEcCtD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.66e-05	0.000584	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—AKT1—thyroid cancer	2.64e-05	0.000579	CbGpPWpGaD
Paclitaxel—Decreased appetite—Epirubicin—thyroid cancer	2.63e-05	0.000232	CcSEcCtD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.63e-05	0.000578	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.63e-05	0.000577	CbGpPWpGaD
Paclitaxel—Hypotension—Doxorubicin—thyroid cancer	2.62e-05	0.000231	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—thyroid cancer	2.61e-05	0.000231	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—CHST14—thyroid cancer	2.61e-05	0.000574	CbGpPWpGaD
Paclitaxel—Fatigue—Epirubicin—thyroid cancer	2.61e-05	0.00023	CcSEcCtD
Paclitaxel—Constipation—Epirubicin—thyroid cancer	2.59e-05	0.000228	CcSEcCtD
Paclitaxel—Pain—Epirubicin—thyroid cancer	2.59e-05	0.000228	CcSEcCtD
Paclitaxel—BCL2—Immune System—TPR—thyroid cancer	2.58e-05	0.000566	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—RXRA—thyroid cancer	2.56e-05	0.000563	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—LGALS3—thyroid cancer	2.56e-05	0.000562	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—TP53—thyroid cancer	2.56e-05	0.000561	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	2.55e-05	0.000225	CcSEcCtD
Paclitaxel—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.54e-05	0.000558	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PRKAR1A—thyroid cancer	2.54e-05	0.000557	CbGpPWpGaD
Paclitaxel—Insomnia—Doxorubicin—thyroid cancer	2.53e-05	0.000223	CcSEcCtD
Paclitaxel—ABCG2—Metabolism—NDUFA13—thyroid cancer	2.53e-05	0.000555	CbGpPWpGaD
Paclitaxel—Paraesthesia—Doxorubicin—thyroid cancer	2.51e-05	0.000222	CcSEcCtD
Paclitaxel—CYP2C8—Biological oxidations—RXRA—thyroid cancer	2.51e-05	0.000552	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NDUFA13—thyroid cancer	2.51e-05	0.00055	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.5e-05	0.000549	CbGpPWpGaD
Paclitaxel—Dyspnoea—Doxorubicin—thyroid cancer	2.5e-05	0.00022	CcSEcCtD
Paclitaxel—Feeling abnormal—Epirubicin—thyroid cancer	2.49e-05	0.00022	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—thyroid cancer	2.49e-05	0.00022	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Epirubicin—thyroid cancer	2.47e-05	0.000218	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—thyroid cancer	2.46e-05	0.000217	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—thyroid cancer	2.43e-05	0.000215	CcSEcCtD
Paclitaxel—TUBB4A—Cell Cycle—TERT—thyroid cancer	2.43e-05	0.000535	CbGpPWpGaD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—thyroid cancer	2.42e-05	0.000213	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—thyroid cancer	2.41e-05	0.000213	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—NRG1—thyroid cancer	2.41e-05	0.000529	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—thyroid cancer	2.41e-05	0.000528	CbGpPWpGaD
Paclitaxel—Urticaria—Epirubicin—thyroid cancer	2.4e-05	0.000212	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—thyroid cancer	2.39e-05	0.000211	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—thyroid cancer	2.39e-05	0.000211	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—thyroid cancer	2.39e-05	0.000211	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—thyroid cancer	2.39e-05	0.000211	CcSEcCtD
Paclitaxel—ABCG2—Metabolism—CHST14—thyroid cancer	2.38e-05	0.000522	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.38e-05	0.000522	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CHST14—thyroid cancer	2.36e-05	0.000518	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—thyroid cancer	2.36e-05	0.000518	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.35e-05	0.000516	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	2.35e-05	0.000516	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	2.35e-05	0.000516	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.31e-05	0.000508	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Doxorubicin—thyroid cancer	2.31e-05	0.000204	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	2.3e-05	0.000505	CbGpPWpGaD
Paclitaxel—Gastrointestinal pain—Doxorubicin—thyroid cancer	2.29e-05	0.000202	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.24e-05	0.000493	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Epirubicin—thyroid cancer	2.23e-05	0.000197	CcSEcCtD
Paclitaxel—TUBB4B—Cell Cycle—TERT—thyroid cancer	2.23e-05	0.000489	CbGpPWpGaD
Paclitaxel—Urticaria—Doxorubicin—thyroid cancer	2.22e-05	0.000196	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	2.22e-05	0.000488	CbGpPWpGaD
Paclitaxel—Abdominal pain—Doxorubicin—thyroid cancer	2.21e-05	0.000195	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—thyroid cancer	2.21e-05	0.000195	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism—HPGD—thyroid cancer	2.19e-05	0.00048	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—HPGD—thyroid cancer	2.18e-05	0.000478	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.17e-05	0.000478	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.17e-05	0.000477	CbGpPWpGaD
Paclitaxel—Asthenia—Epirubicin—thyroid cancer	2.17e-05	0.000192	CcSEcCtD
Paclitaxel—Pruritus—Epirubicin—thyroid cancer	2.14e-05	0.000189	CcSEcCtD
Paclitaxel—CYP3A5—Metabolism—MINPP1—thyroid cancer	2.13e-05	0.000468	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—HPGD—thyroid cancer	2.11e-05	0.000463	CbGpPWpGaD
Paclitaxel—Diarrhoea—Epirubicin—thyroid cancer	2.07e-05	0.000183	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—thyroid cancer	2.06e-05	0.000182	CcSEcCtD
Paclitaxel—CYP2C9—Biological oxidations—RXRA—thyroid cancer	2.04e-05	0.000449	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TCF7L1—thyroid cancer	2.04e-05	0.000448	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	2.03e-05	0.000446	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.02e-05	0.000444	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	2.01e-05	0.000442	CbGpPWpGaD
Paclitaxel—Asthenia—Doxorubicin—thyroid cancer	2.01e-05	0.000177	CcSEcCtD
Paclitaxel—Dizziness—Epirubicin—thyroid cancer	2e-05	0.000177	CcSEcCtD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2e-05	0.000439	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.99e-05	0.000438	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—AKT1—thyroid cancer	1.99e-05	0.000437	CbGpPWpGaD
Paclitaxel—Pruritus—Doxorubicin—thyroid cancer	1.98e-05	0.000175	CcSEcCtD
Paclitaxel—Vomiting—Epirubicin—thyroid cancer	1.92e-05	0.00017	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—thyroid cancer	1.92e-05	0.000169	CcSEcCtD
Paclitaxel—ABCG2—Metabolism—HPGD—thyroid cancer	1.92e-05	0.000421	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—HRAS—thyroid cancer	1.91e-05	0.000421	CbGpPWpGaD
Paclitaxel—Rash—Epirubicin—thyroid cancer	1.91e-05	0.000168	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—thyroid cancer	1.91e-05	0.000168	CcSEcCtD
Paclitaxel—CYP3A7—Metabolism—HPGD—thyroid cancer	1.9e-05	0.000417	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.9e-05	0.000417	CbGpPWpGaD
Paclitaxel—Headache—Epirubicin—thyroid cancer	1.9e-05	0.000167	CcSEcCtD
Paclitaxel—Dizziness—Doxorubicin—thyroid cancer	1.85e-05	0.000163	CcSEcCtD
Paclitaxel—CYP2C8—Metabolism—MINPP1—thyroid cancer	1.85e-05	0.000405	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NDUFA13—thyroid cancer	1.81e-05	0.000398	CbGpPWpGaD
Paclitaxel—Nausea—Epirubicin—thyroid cancer	1.8e-05	0.000159	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—thyroid cancer	1.78e-05	0.000157	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.77e-05	0.00039	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—TPR—thyroid cancer	1.77e-05	0.000389	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.77e-05	0.000388	CbGpPWpGaD
Paclitaxel—Rash—Doxorubicin—thyroid cancer	1.77e-05	0.000156	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—thyroid cancer	1.76e-05	0.000156	CcSEcCtD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.76e-05	0.000386	CbGpPWpGaD
Paclitaxel—Headache—Doxorubicin—thyroid cancer	1.75e-05	0.000155	CcSEcCtD
Paclitaxel—BCL2—Immune System—CDK1—thyroid cancer	1.75e-05	0.000384	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	1.74e-05	0.000382	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.71e-05	0.000375	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	1.71e-05	0.000375	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CHST14—thyroid cancer	1.7e-05	0.000374	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.7e-05	0.000373	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CCND1—thyroid cancer	1.7e-05	0.000373	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—AKT1—thyroid cancer	1.69e-05	0.000371	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.68e-05	0.00037	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IFNA2—thyroid cancer	1.68e-05	0.000369	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.68e-05	0.000369	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—TPR—thyroid cancer	1.66e-05	0.000366	CbGpPWpGaD
Paclitaxel—Nausea—Doxorubicin—thyroid cancer	1.66e-05	0.000147	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—PRKAR1A—thyroid cancer	1.64e-05	0.00036	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—PPARG—thyroid cancer	1.62e-05	0.000356	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MINPP1—thyroid cancer	1.61e-05	0.000353	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.58e-05	0.000346	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.57e-05	0.000346	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NDUFA13—thyroid cancer	1.57e-05	0.000345	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	1.52e-05	0.000333	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MINPP1—thyroid cancer	1.5e-05	0.00033	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TPR—thyroid cancer	1.49e-05	0.000328	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.48e-05	0.000326	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.48e-05	0.000325	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CHST14—thyroid cancer	1.47e-05	0.000324	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PRKAR1A—thyroid cancer	1.47e-05	0.000323	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.44e-05	0.000316	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CCND1—thyroid cancer	1.41e-05	0.000309	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MEN1—thyroid cancer	1.4e-05	0.000308	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRG1—thyroid cancer	1.4e-05	0.000308	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HPGD—thyroid cancer	1.37e-05	0.000302	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NDUFA13—thyroid cancer	1.37e-05	0.0003	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.35e-05	0.000296	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	1.32e-05	0.000291	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CCND1—thyroid cancer	1.29e-05	0.000283	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CHST14—thyroid cancer	1.29e-05	0.000282	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	1.28e-05	0.000281	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NDUFA13—thyroid cancer	1.28e-05	0.000281	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.27e-05	0.000279	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	1.27e-05	0.000279	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—TPR—thyroid cancer	1.26e-05	0.000276	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—TPR—thyroid cancer	1.25e-05	0.000275	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.25e-05	0.000275	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—SLC5A5—thyroid cancer	1.25e-05	0.000274	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.24e-05	0.000273	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	1.24e-05	0.000271	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PRKAR1A—thyroid cancer	1.23e-05	0.00027	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—TPR—thyroid cancer	1.21e-05	0.000266	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PTEN—thyroid cancer	1.21e-05	0.000265	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CHST14—thyroid cancer	1.2e-05	0.000264	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PRKAR1A—thyroid cancer	1.19e-05	0.000261	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HPGD—thyroid cancer	1.19e-05	0.000261	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.18e-05	0.000258	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.17e-05	0.000257	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.12e-05	0.000246	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—thyroid cancer	1.12e-05	0.000246	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CALCA—thyroid cancer	1.12e-05	0.000246	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.12e-05	0.000245	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—RXRA—thyroid cancer	1.11e-05	0.000244	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TPR—thyroid cancer	1.1e-05	0.000242	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TPR—thyroid cancer	1.09e-05	0.00024	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PRKAR1A—thyroid cancer	1.08e-05	0.000238	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.08e-05	0.000238	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.08e-05	0.000237	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NRAS—thyroid cancer	1.08e-05	0.000236	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	1.07e-05	0.000236	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—RXRA—thyroid cancer	1.05e-05	0.00023	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HPGD—thyroid cancer	1.04e-05	0.000228	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.02e-05	0.000224	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDK1—thyroid cancer	1.01e-05	0.000222	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.99e-06	0.00022	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MINPP1—thyroid cancer	9.9e-06	0.000218	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HPGD—thyroid cancer	9.68e-06	0.000213	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.64e-06	0.000212	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.51e-06	0.000209	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—SLC5A5—thyroid cancer	9.4e-06	0.000207	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—SLC5A5—thyroid cancer	9.36e-06	0.000206	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—thyroid cancer	9.26e-06	0.000204	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—KRAS—thyroid cancer	9.26e-06	0.000203	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SLC5A5—thyroid cancer	9.05e-06	0.000199	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	9.03e-06	0.000198	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.81e-06	0.000194	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.77e-06	0.000193	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.72e-06	0.000191	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.48e-06	0.000186	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—thyroid cancer	8.47e-06	0.000186	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NDUFA13—thyroid cancer	8.42e-06	0.000185	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SLC5A5—thyroid cancer	8.24e-06	0.000181	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SLC5A5—thyroid cancer	8.16e-06	0.000179	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRG1—thyroid cancer	8.12e-06	0.000178	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.99e-06	0.000176	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CHST14—thyroid cancer	7.92e-06	0.000174	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—RXRA—thyroid cancer	7.9e-06	0.000174	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TPR—thyroid cancer	7.88e-06	0.000173	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HRAS—thyroid cancer	7.87e-06	0.000173	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—RXRA—thyroid cancer	7.87e-06	0.000173	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.85e-06	0.000172	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	7.76e-06	0.00017	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.68e-06	0.000169	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.65e-06	0.000168	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—RXRA—thyroid cancer	7.61e-06	0.000167	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.4e-06	0.000163	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TERT—thyroid cancer	7.29e-06	0.00016	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PTEN—thyroid cancer	7.02e-06	0.000154	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PPARG—thyroid cancer	7.02e-06	0.000154	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HIF1A—thyroid cancer	6.97e-06	0.000153	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—AKT1—thyroid cancer	6.95e-06	0.000153	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—RXRA—thyroid cancer	6.92e-06	0.000152	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—RXRA—thyroid cancer	6.86e-06	0.000151	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TPR—thyroid cancer	6.83e-06	0.00015	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	6.72e-06	0.000148	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.69e-06	0.000147	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PPARG—thyroid cancer	6.61e-06	0.000145	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—AKT1—thyroid cancer	6.4e-06	0.000141	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HPGD—thyroid cancer	6.38e-06	0.00014	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—thyroid cancer	6.27e-06	0.000138	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.09e-06	0.000134	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TPR—thyroid cancer	5.95e-06	0.000131	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.95e-06	0.000131	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC5A5—thyroid cancer	5.9e-06	0.00013	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PRKAR1A—thyroid cancer	5.85e-06	0.000129	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BRAF—thyroid cancer	5.77e-06	0.000127	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TPR—thyroid cancer	5.56e-06	0.000122	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—thyroid cancer	5.53e-06	0.000121	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	5.47e-06	0.00012	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—thyroid cancer	5.39e-06	0.000119	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—thyroid cancer	5.2e-06	0.000114	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC5A5—thyroid cancer	5.11e-06	0.000112	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.02e-06	0.00011	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARG—thyroid cancer	4.99e-06	0.00011	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARG—thyroid cancer	4.97e-06	0.000109	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—RXRA—thyroid cancer	4.96e-06	0.000109	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.96e-06	0.000109	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTEN—thyroid cancer	4.82e-06	0.000106	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARG—thyroid cancer	4.8e-06	0.000106	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.79e-06	0.000105	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—thyroid cancer	4.66e-06	0.000102	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—thyroid cancer	4.58e-06	0.000101	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—thyroid cancer	4.54e-06	9.96e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC5A5—thyroid cancer	4.45e-06	9.78e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARG—thyroid cancer	4.37e-06	9.6e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARG—thyroid cancer	4.33e-06	9.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—RXRA—thyroid cancer	4.29e-06	9.44e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.18e-06	9.18e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC5A5—thyroid cancer	4.16e-06	9.14e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—thyroid cancer	4.07e-06	8.94e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—thyroid cancer	4.05e-06	8.89e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—thyroid cancer	3.92e-06	8.62e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—thyroid cancer	3.91e-06	8.58e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.9e-06	8.56e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—thyroid cancer	3.78e-06	8.3e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—RXRA—thyroid cancer	3.74e-06	8.22e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TPR—thyroid cancer	3.67e-06	8.05e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—thyroid cancer	3.63e-06	7.97e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.61e-06	7.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—RXRA—thyroid cancer	3.5e-06	7.68e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—thyroid cancer	3.44e-06	7.55e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—thyroid cancer	3.42e-06	7.52e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—thyroid cancer	3.41e-06	7.49e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—thyroid cancer	3.41e-06	7.48e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.4e-06	7.47e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—thyroid cancer	3.3e-06	7.24e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARG—thyroid cancer	3.13e-06	6.88e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—thyroid cancer	3.12e-06	6.86e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—thyroid cancer	3e-06	6.59e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—thyroid cancer	2.97e-06	6.53e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—thyroid cancer	2.78e-06	6.1e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.74e-06	6.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARG—thyroid cancer	2.71e-06	5.96e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—thyroid cancer	2.66e-06	5.83e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—thyroid cancer	2.61e-06	5.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—thyroid cancer	2.46e-06	5.41e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARG—thyroid cancer	2.36e-06	5.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—thyroid cancer	2.34e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—RXRA—thyroid cancer	2.31e-06	5.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARG—thyroid cancer	2.21e-06	4.85e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—thyroid cancer	2.15e-06	4.72e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—thyroid cancer	2.13e-06	4.69e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—thyroid cancer	1.97e-06	4.33e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—thyroid cancer	1.96e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—thyroid cancer	1.9e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—thyroid cancer	1.86e-06	4.09e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—thyroid cancer	1.86e-06	4.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.74e-06	3.81e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—thyroid cancer	1.73e-06	3.8e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—thyroid cancer	1.71e-06	3.76e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—thyroid cancer	1.62e-06	3.56e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—thyroid cancer	1.51e-06	3.33e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARG—thyroid cancer	1.46e-06	3.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—thyroid cancer	1.24e-06	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.15e-06	2.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—thyroid cancer	1.07e-06	2.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—thyroid cancer	9.99e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—thyroid cancer	9.34e-07	2.05e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—thyroid cancer	8.73e-07	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—thyroid cancer	5.75e-07	1.26e-05	CbGpPWpGaD
